Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Farmers Insurance
McKesson
Cerilliant
Queensland Health
Colorcon
Deloitte
Express Scripts
Healthtrust
Boehringer Ingelheim

Generated: January 21, 2018

DrugPatentWatch Database Preview

Estradiol; norethindrone acetate - Generic Drug Details

« Back to Dashboard

What are the generic sources for estradiol; norethindrone acetate and what is the scope of estradiol; norethindrone acetate freedom to operate?

Estradiol; norethindrone acetate
is the generic ingredient in four branded drugs marketed by Noven Pharms Inc, Amneal Pharms Llc, Lupin Ltd, Barr, Breckenridge Pharm, Mylan Labs Ltd, and Teva Pharms Usa, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are seventy-five drug master file entries for estradiol; norethindrone acetate. Eight suppliers are listed for this compound.
Summary for estradiol; norethindrone acetate
Pharmacology for estradiol; norethindrone acetate

US Patents and Regulatory Information for estradiol; norethindrone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa ESTRADIOL AND NORETHINDRONE ACETATE estradiol; norethindrone acetate TABLET;ORAL 200747-001 Mar 8, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Breckenridge Pharm ESTRADIOL AND NORETHINDRONE ACETATE estradiol; norethindrone acetate TABLET;ORAL 078324-001 Apr 17, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Noven Pharms Inc COMBIPATCH estradiol; norethindrone acetate FILM, EXTENDED RELEASE;TRANSDERMAL 020870-001 Aug 7, 1998 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr ESTRADIOL AND NORETHINDRONE ACETATE estradiol; norethindrone acetate TABLET;ORAL 079193-001 May 11, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms Llc ACTIVELLA estradiol; norethindrone acetate TABLET;ORAL 020907-001 Nov 18, 1998 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Labs Ltd ESTRADIOL AND NORETHINDRONE ACETATE estradiol; norethindrone acetate TABLET;ORAL 207261-001 Feb 10, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Noven Pharms Inc COMBIPATCH estradiol; norethindrone acetate FILM, EXTENDED RELEASE;TRANSDERMAL 020870-002 Aug 7, 1998 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lupin Ltd AMABELZ estradiol; norethindrone acetate TABLET;ORAL 203339-002 Jun 20, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms Llc ACTIVELLA estradiol; norethindrone acetate TABLET;ORAL 020907-002 Dec 28, 2006 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Labs Ltd ESTRADIOL AND NORETHINDRONE ACETATE estradiol; norethindrone acetate TABLET;ORAL 207261-002 Feb 10, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for estradiol; norethindrone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Noven Pharms Inc COMBIPATCH estradiol; norethindrone acetate FILM, EXTENDED RELEASE;TRANSDERMAL 020870-002 Aug 7, 1998 ➤ Subscribe ➤ Subscribe
Noven Pharms Inc COMBIPATCH estradiol; norethindrone acetate FILM, EXTENDED RELEASE;TRANSDERMAL 020870-001 Aug 7, 1998 ➤ Subscribe ➤ Subscribe
Noven Pharms Inc COMBIPATCH estradiol; norethindrone acetate FILM, EXTENDED RELEASE;TRANSDERMAL 020870-002 Aug 7, 1998 ➤ Subscribe ➤ Subscribe
Noven Pharms Inc COMBIPATCH estradiol; norethindrone acetate FILM, EXTENDED RELEASE;TRANSDERMAL 020870-001 Aug 7, 1998 ➤ Subscribe ➤ Subscribe
Noven Pharms Inc COMBIPATCH estradiol; norethindrone acetate FILM, EXTENDED RELEASE;TRANSDERMAL 020870-002 Aug 7, 1998 ➤ Subscribe ➤ Subscribe
Noven Pharms Inc COMBIPATCH estradiol; norethindrone acetate FILM, EXTENDED RELEASE;TRANSDERMAL 020870-001 Aug 7, 1998 ➤ Subscribe ➤ Subscribe
Noven Pharms Inc COMBIPATCH estradiol; norethindrone acetate FILM, EXTENDED RELEASE;TRANSDERMAL 020870-001 Aug 7, 1998 ➤ Subscribe ➤ Subscribe
Noven Pharms Inc COMBIPATCH estradiol; norethindrone acetate FILM, EXTENDED RELEASE;TRANSDERMAL 020870-002 Aug 7, 1998 ➤ Subscribe ➤ Subscribe
Amneal Pharms Llc ACTIVELLA estradiol; norethindrone acetate TABLET;ORAL 020907-001 Nov 18, 1998 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Novartis
Federal Trade Commission
Fish and Richardson
Citi
Chubb
Harvard Business School
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot